Accumulation of Genetic and Epigenetic Alterations in Normal Cells and Cancer Risk
Overview
Authors
Affiliations
Cancers develop due to the accumulation of genetic and epigenetic alterations. Genetic alterations are induced by aging, mutagenic chemicals, ultraviolet light, and other factors; whereas, epigenetic alterations are mainly by aging and chronic inflammation. The accumulation and patterns of alterations in normal cells reflect our past exposure levels and life history. Most accumulated alterations are considered as passengers, but their accumulation is correlated with cancer drivers. This has been shown for aberrant DNA methylation but has only been speculated for genetic alterations. However, recent technological advancements have enabled measurement of rare point mutations, and studies have shown that their accumulation levels are indeed correlated with cancer risk. When the accumulation levels of aberrant DNA methylation and point mutations are combined, risk prediction becomes even more accurate. When high levels of alterations accumulate, the tissue has a high risk of developing cancer or even multiple cancers and is considered as a "cancerization field", with or without expansion of physiological patches of clonal cells. In this review, we describe the formation of a cancerization field and how we can apply its detection in precision cancer risk diagnosis.
Zeng H, Yin C, Chai C, Wang Y, Dai Q, Sun H Brief Bioinform. 2025; 26(2).
PMID: 40072848 PMC: 11899576. DOI: 10.1093/bib/bbaf113.
Megdiche Y, Salerno-Goncalves R Front Immunol. 2025; 16:1547213.
PMID: 40040700 PMC: 11876029. DOI: 10.3389/fimmu.2025.1547213.
Deciphering the oncogenic influence of : Implications of matrix metalloproteinase activation.
Nambiar J, Venugopal M, Shaji S, Bose C, Rajeev A, Kalliadan S Heliyon. 2025; 11(4):e42538.
PMID: 40028520 PMC: 11870157. DOI: 10.1016/j.heliyon.2025.e42538.
Mahdi Khamaneh A, Jafari-Gharabaghlou D, Ansarin K, Pazooki P, Akbarpour Z, Naghili B Oncol Rev. 2025; 19:1516409.
PMID: 40017494 PMC: 11861078. DOI: 10.3389/or.2025.1516409.
Zhao J, Liu Y, Zhou L, Liu Y Genes (Basel). 2025; 16(2).
PMID: 40004479 PMC: 11855459. DOI: 10.3390/genes16020150.